drugset / Trial / NCT06559007
Phase 1 Study to Evaluate PK, Safety, and Tolerability of HRS-5041 in Healthy Caucasian Male Participants
RandomizedSequentialOpen-labelTreatment
Summary
This is a phase 1, open-label, randomized study. The objective of this study is to evaluate the PK, safety and tolerability of orally administered single-dose HRS-5041 in healthy Caucasian male participants.
Timeline
- Start
- 2024-09-25
- Primary completion
- 2025-01-06
- Completion
- 2025-03-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | HRS-5041 | Other / unclassified | — | Oral |